NCT07388524 2026-03-17
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
National Cancer Institute (NCI)
Phase 3 Not yet recruiting
National Cancer Institute (NCI)
Guangdong Provincial People's Hospital
Mayo Clinic
Centre Leon Berard
Centre hospitalier de l'Université de Montréal (CHUM)
Peking Union Medical College Hospital